Microvasculature in Acute Myocardial Ischemia: Part II. Evolving Concepts in Pathophysiology, Diagnosis, and Treatment

Circulation

Volumn 109, Issue 3, 2004, Pages 310-315

  Kaul, Sanjiv ^a,c   Ito, Hiroshi ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Sakurabashi Watanabe Hospital   (Japan)

^c UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE; ANTITHROMBOCYTIC AGENT; CALCIUM ANTAGONIST; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; NICORANDIL; PAPAVERINE; PLACEBO; POTASSIUM CHANNEL STIMULATING AGENT; TICLOPIDINE; VASODILATOR AGENT; VERAPAMIL;

ACUTE HEART INFARCTION; ADJUVANT THERAPY; CLINICAL TRIAL; COLLATERAL CIRCULATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; HEART INFARCTION SIZE; HEART MUSCLE PERFUSION; HUMAN; IMAGING SYSTEM; INFLAMMATION; INTRACORONARY INFUSION; ISCHEMIC HEART DISEASE; MICROVASCULATURE; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM;

ANIMALS; CORONARY CIRCULATION; CORONARY VESSELS; DOGS; HUMANS; MICROCIRCULATION; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; VASCULITIS;

EID: 1642580536     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000111583.89777.F9     Document Type: Review

References (53)

1. Kaul S, Senior R, Firschke C, et al. Incremental value of cardiac imaging in patients presenting to the emergency department with chest pain and without ST-segment elevation: a multicenter study. Am Heart J. In press.
2. Kaul S. Coronary angiography cannot be used to assess myocardial perfusion in patients undergoing reperfusion for acute myocardial infarction. Heart. 2001;86:483-484.
3. Villanueva FS, Glasheen WP, Sklenar J, et al. Characterization of spatial patterns of flow within the reperfused myocardium using myocardial contrast echocardiography: implications in determining the extent of myocardial salvage. Circulation. 1993;88:2596-2606.
4. Villanueva FS, Camarano G, Ismail S, et al. Coronary reserve abnormalities during post-infarct reperfusion: implications for the timing of myocardial contrast echocardiography to assess myocardial viability. Circulation. 1996;94:748-754.
5. Ragosta M, Camarano GP, Kaul S, et al. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: new insights using myocardial contrast echocardiography. Circulation. 1994;89:2562-2569.
6. Sakuma T, Hayashi Y, Sumii K, et al. Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization. J Am Coll Cardiol. 1998;32:890-897.
7. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54:1496-1508.
8. Kloner RA, Rude RE, Carlson N, et al. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation. 1980;62:945-952.
9. Ambrosio G, Weisman HF, Mannisi JA, et al. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 1989;80:1846-1861.
10. Kloner RA. Does reperfusion injury exist in humans? J Am Coll Cardiol. 1993;21:537-545.
11. Davies MJ, Thomas AC, Knapman PA, et al. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation. 1986;73:418-427.
12. Frink RJ, Rooney PA Jr, Trowbridge JO, et al. Coronary thrombosis and platelet/fibrin microemboli in death associated with acute myocardial infarction. Br Heart J. 1988;59:196-200.
13. Yao S-K, Ober JC, McNatt J, et al. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries. Circ Res. 1992;70:39-48.
14. Hirsh PD, Hillis LD, Campbell WB, et al. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med. 1981;304:685-691.
15. Kotani J, Nanto S, Mintz GS, et al. Plaque gruel of atheromatous coronary lesion may contribute to the no reflow phenomenon in patients with acute coronary syndrome. Circulation. 2002;106:1672-1677.
16. Ito H, Okamura A, Iwakura K, et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 1996;93:1993-1999.
17. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation. 1992;85:1699-1705.
18. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the "no reflow" phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93:223-228.
19. Iwakura K, Ito H, Takiuchi S. et al. Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. Circulation. 1996;94:1269-1275.
20. Kajiya F, Tsujioka K, Goto M, et al. Functional characteristics of intramyocardial capacitance vessels during diastole in the dogs. Circ Res. 1986;58:476-485.
21. Kawamoto T, Yosida K, Akasaka T, et al. Can coronary blood flow velocity pattern after primary percutaneous transluminal coronary angioplasty predicts recovery of regional left ventricular function in patients with acute myocardial infarction? Circulation. 1999;100:339-345.
22. Yamamuro A, Akasaka T, Tamita K, et al. Coronary flow velocity pattern immediately after percutaneous coronary intervention as a predictor of complications and in-hospital survival after acute myocardial infarction. Circulation. 2002;106:3051-3056.
23. Yamamoto K, Ito H, Iwakura K, et al. Pressure-derived collateral flow index as a parameter of microvascular dysfunction in acute myocardial infarction. J Am Coll Cardiol. 2001;38:1383-1389.
24. Yamamoto K, Ito H, Iwakura K, et al. Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction flow grade 2 in acute myocardial infarction: insight into mechanisms of microvascular dysfunction. J Am Coll Cardiol. 2002;40:1755-1760.
25. Akasaka T, Yoshida K, Kawamoto T, et al. Relation of phasic coronary flow velocity characteristics with TIM1 perfusion grade and myocardial recovery after primary percutaneous transluminal coronary angioplasty and rescue stenting. Circulation. 2000;101:2361-2367.
26. Iwakura K, Ito H, Nishikawa N, et al. Early temporal changes in coronary flow velocity patterns in patients with acute myocardial infarction demonstrating the "no-reflow" phenomenon. Am J Cardiol. 1999;84:415-419.
27. Komamura K, Kitakaze M, Nishida K, et al. Progressive decreases in coronary vein flow during reperfusion in acute myocardial infarction: clinical documentation of the no reflow phenomenon after successful thrombolysis. J Am Coll Cardiol. 1994;24:370-377.
28. Asanuma T, Tanabe K, Ochiai K, et al. Relationship between progressive microvascular damage and intramyocardial hemorrhage in patients with reperfused anterior myocardial infarction: myocardial contrast echocardiographic study. Circulation. 1997;96:448-453.
29. Gregorini L, Marco J, Kozakova M, et al. α-Adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation. 1999;99:482-490.
30. Tanaka A, Kawarabayashi T, Nishibori Y, et al. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation. 2002;105:2148-2152.
31. Iwakura K, Ito H, Kawano S, et al. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol. 2001;38:472-477.
32. Iwakura K, Ito H, Ikushima M, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003;41:1-7.
33. Willerson JT, Hutcheson DR, Leshin SJ, et al. Serum glucagon and insulin levels and their relationship to blood glucose values in patients with acute myocardial infarction and acute coronary insufficiency. Am J Med. 1974;57:747-752.
34. Reimer KA, Jennings RB. The "wave front phenomenon" of myocardial ischemic cell death, II: transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral blood flow. Lab Invest. 1979;40:633-644.
35. Schaper W, Frenzel H, Hort W. Experimental coronary artery occlusion, I: measurement of infarct size. Basic Res Cardiol. 1979;74:46-53.
36. Coggins MP, Le DE, Wei K, et al. Noninvasive prediction of ultimate infarct size at the time of acute coronary occlusion based on the extent and magnitude of collateral-derived myocardial blood flow. Circulation. 2001;104:2471-2477.
37. Sabia PJ, Powers ER, Ragosta M, et al. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med. 1992;372:1825-1831.
38. Sabia PJ, Powers ER, Jayaweera AR, et al. Functional significance of collateral blood flow in patients with recent acute myocardial infarction: a study using myocardial contrast echocardiography. Circulation. 1992;85:2080-2089.
39. Grill HP, Brinkner JA, Tanbe J, et al. Contrast echocardiographic mapping of collateralized myocardium in humans before and after coronary angioplasty. J Am Coll Cardiol. 1990;16:1594-1600.
40. Swinburn JMA, Lahiri A, Senior R. Intravenous myocardial contrast echocardiography predicts recovery of function early after acute myocardial infarction. J Am Coll Cardiol. 2001;38:19-25.
41. Lindner JR, Song J, Xu F, et al. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation. 2000;102:2745-2750.
42. Christiansen JP, Leong-Poi H, Klibanov AL, et al. Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation. 2002;105:1764-1767.
43. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 2001;344:1895-1903.
44. Ishihara M, Sato H, Tateishi H, et al. Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine. Am Heart J. 1996;132:959-963.
45. Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of "no reflow" after percutaneous coronary intervention. Circulation. 1994;89:2514-2518.
46. Taniyama Y, Ito H, Iwakura K, et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol. 1997;30:1193-1199.
47. Marzilli M, Orsini E, Marraccini P, et al. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation. 2000;101:2154-2159.
48. Mahaffey KW, Puma JA, Barbagelata A, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial-the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol. 1999;34:1171-1120.
49. Sato T, Sasaki N, O'Rourke B, et al. Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol. 2000;35:514-518.
50. Ito H, Taniyama Y, lwakura K, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol. 1999;33:654-660.
51. Sakuma T, Leong-Poi H, Fisher NG, et al. Further insights into the "no-reflow" phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli. J Am Soc Echocardiogr. 2003;16:15-21.
52. Tillmanns H, Leinberger H, Neumann FJ, et al. Myocardial microcirculation in the beating heart: in vivo microscopic studies. In: Spaan JAE, Bruschke AVG. Gittenberger-de Groot AC, eds. Coronary Circulation. Dordrecht, the Netherlands: Martin Nijhoff Publishers; 1987:88-94.
53. Kaul S, Pandian NG, Guerrero JL, et al. Effects of selectively altering the collateral driving pressure on regional perfusion and function in the occluded coronary bed in the dog. Circ Res. 1987;61:77-85.